Ingrid Delaet sold $2.6M of Neurocrine Biosciences (NBIX)

Executed Jul 7, disclosed Jul 9, 2 days later.

Value, as filed

$2.6M

14,571 sh across 3 lots

Executed

Jul 7

the trade date, as filed

Disclosed

Jul 9

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

ID Ingrid Delaet Chief Regulatory Officer profile →

Ingrid Delaet (Chief Regulatory Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $2.6M of NBIX (14,571 sh across 3 lots, as filed), executed Jul 7.

The name

NBIX Neurocrine Biosciences, Inc. NBIX · Healthcare · 59 filings in 24 months ticker →

Healthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Ingrid Delaet in NBIX

NBIXSALE Neurocrine Biosciences, Inc. $791K
4,367 sh × $181.02
Exec Jul 10
Filed Jul 13 · 4:27 PM ET NBIXSALE Neurocrine Biosciences, Inc. $354K
2,261 sh × $156.71
Exec May 29
Filed Jun 2 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $147K
1,091 sh × $135.00
Exec Dec 17 2024
Filed Dec 19 2024 · 5:30 PM ET